Block 1 Part 2 Flashcards
hormone CCK
cholesytokinin - produced by intestine when it senses FA - releases bile (amphipathic form of cholesterol)
secretin
hormone that stimulates pancreatic release of bicarbonate to neutralize stomach acid
orlistat
drug that inhibits all lipases
enzymes involved in fat metabolism
cholesterol esterase (cholesterol ester to cholesterol); phospholipase A2 (removes last fatty acid on triglyceride - usually sn2 position) lipase/co-lipase
function of enterocytes in TG metabolism
uptake, re-esterify FA and cholesterol –>chylomicrons (carry ApoB48) travel through lymph to blood, transporting triglycerides to adipose, muscle, and heart cells
Blood LPL rips off free FA from chylomicron—>FA to cells, leaving chylomicron remnants. Liver converts depleted chylomicron remnants into lipoproteins VLDL, uptakes LDL, secretes HDL
FA Synthesis
add 2C/cycle (requires transport into cytoplasm) Key players: mitochondrial ACC (acetyl CoA carboxylase, +biotin), cytosolic FA synthase (+biotin), Malate-Citrate Shuttle (transport from mt—>ct) 1. Mitochondria: Acetyl CoA+CO2—>malonyl CoA (via ACC) 2. Malate-Citrate shuttle: transports malonyl CoA from mitochondria into cytoplasm (citrate vs pyruvate transporter) 3. Cytoplasm: malonyl coA+acyl carrier+Acetyl CoA—> Palmitate (via FA synthase) *Each round adds 2C (from Acetyl CoA), generating Palmitate
enzymes involved in FA synthesis
acetyl coA carboxylase (ACC: acetyl coA -> malonyl coA)
malate-citrate shuttle
FA synthase (BIOTIN)
hormonal regulation of FA synthesis
insulin: activates phosphatase that activates ACC
glucagon/epinephrin: activate cAMP-dependent PKA - inactivates ACC
main enzymes involved in FA metabolism
- FA caA synthethase (outer membrane of mitochondria - “activates” FA by making FA coA it can now move into IM space)
- CPT1 (carnitine palmitoyl transferase - makes FAcarnitine that can move into matrix)
- CPTII (makes FA coA and carnitine in matrix)
beta oxidation
oxidize to double bond between alpha and beta; ox to hydroxyl; ox to carbonyl; thiolysis by coA –> FADH2, NADH2, acetyl coA
MCAD - medium chain acetyl dehydrogenase (makes a-b double bond)
LCAD - long chain …
hormonal regulation of beta ox
- insulin –> phosphatase –> ACC –> malonyl coA –| CPT1 –| beta ox
- glucagon/epinephrin –> PKA –| ACC – low levels of malonyl coA –> CPT1 active –> beta ox
ketone bodies
acetoacetate, beta hydroxybutyrate, acetone.
acetyl coA cannot enter TCA b/c oxaloacetate is depleted (used up in gluconeogenesis)
liver cannot use ketone bodies that well
MCADD
cannot reduce medium chain FAs into acyl CoA for beta oxidation
Labs: low ketones* (minimal ketones made), low glucose, accumulation of C8-acylcarnitine (confirm with mass spec, enzyme assay) *can still make minimal ketones (vs LCADD)
Clinical presentation: baby not fed overnight, presents with seizure in the AM
LCADD
can’t breakdown long chain FA into acyl CoA for beta oxidation
Labs: low glucose, NO ketones*, brown urine (rhabdomyolysis), accumulation of long chain FA (mass spec), confirm with enzyme assay *LC FA require LCAD for any beta oxidation/ketone generation
Clinical presentation: child with minor URI triggers crisis with fever, low PO intake, progressive sleepiness and difficult to arouse
FAOD Treatment: start high glucose ASAP, avoid fasting for >8- 12h, carnitine supplementation (maximize transport into mitochondria)
(muscle uses long chain; liver medium chain)
rhabdomyolysis
muscle breakdown
HMG coA reductase
enzyme for cholesterol synthesis
ACAT
converts free cholesterol in cytosol to lipid droplets
LDL uptake consequences
uptake by LDLR –> (-) HMG coA reductase activity; (+) ACAT activity
statins
inhibit HMGcoA reductase –> low intracellular cholesterol–> SRBP2 on –> (+) LDLR
SREBP Pathway
(+) LDLR and HMG coAR –> (-) plasma LDL; (+) Insig (inactivates SREBP = negative feedback)
activated by low cholesterol and insulin
low cholesterol -> SREBP activated, docked by SCAP; transported to golgi, cleaved by S1P (membrane protein) and S2P. high cholesterol -> cholesterol binds to SCAP and Insig
LXR-RXR
transcription factor that increases enzymes important for excreting cholesterol; increase bile salt formation; activates SREBP1
activated by high cholesterol
PCSK9 inhibitors
when used w statin massively increase LDLR
arachidonic acid
used by the body to synthesize 20C FA and 5member ring
how NH3+ travels in the blood
alanine, glutamate, glutamine